Home Newsfeeds Silo Pharma Advances Clinical Study Analyzing Effects Of Psilocybin On Inflammation

Silo Pharma Advances Clinical Study Analyzing Effects Of Psilocybin On Inflammation

Parkinson's disease, bipolar disorder, and chronic pain targeted in study Study aims to support psilocybin as a potential therapeutic for inflammatory disorders

byBenzinga Newsdesk

January 10, 2023

1 minute read

Parkinson’s disease, bipolar disorder, and chronic pain targeted in study

Study aims to support psilocybin as a potential therapeutic for inflammatory disorders

$1000 Invested In This Stock 15 Years Ago Would Be Worth $13,000 Today

By Benzinga Insights

March 29, 1:30 PM

Taiwan Semiconductor (NYSE:TSM) has outperformed the market over the past 15 years by 6.17% on an annualized basis…

TSM

Rocket Companies CEO Jay Farner To Step Down After 27 Years With Lender: What’s Next?

By Aaron Bry

February 13, 11:41 AM

Rocket Companies Inc (NYSE: RKT) announced Monday that CEO Jay Farner will step down from his position in June after more than 27 years with the company.

RKT

Movers
News

Why Ugg’s Parent-Company Deckers Outdoor Corporation Stock Soared Today

By Erica Kollmann

October 27, 4:43 PM

Deckers Outdoor Corporation (NYSE: DECK) shares traded higher Friday after the company reported a year-over-year increase in second-quarter earnings per share and better-than-expected sales resu

DECK

OP Bancorp Q4 EPS $0.51 Misses $0.58 Estimate

By Benzinga Newsdesk

January 26, 5:33 PM

OP Bancorp (NASDAQ:OPBK) reported quarterly earnings of $0.51 per share which missed the analyst consensus estimate of $0.58 by 12.07 percent. This is a 13.56 percent decrease over earnings of $0.59 per share from the

OPBK

Silo Pharma Advances Clinical Study Analyzing Effects Of Psilocybin On Inflammation

Related Posts

$1000 Invested In This Stock 15 Years Ago Would Be Worth $13,000 Today

Rocket Companies CEO Jay Farner To Step Down After 27 Years With Lender: What’s Next?

Why Ugg’s Parent-Company Deckers Outdoor Corporation Stock Soared Today

OP Bancorp Q4 EPS $0.51 Misses $0.58 Estimate